CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Clinical experiences with Infliximab and Adalimumab in a single centre cohort of patients with inflammatory bowel disease
DOI 10.1055/s-0033-1347461
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Csöndes, A Szabó, T Kárász, S Pekárdi, I Rácz
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: In recent years, biological therapies targeting TNF alfa have significantly improved the management of IBD refractory to conventional therapies. Our aim was to summarise our experiences of biological agents in inflammatory bowel disease (IBD). Patients and methods: Data of 86 patients with IBD were analysed [Crohn disease (CD)/ulcerative colitis (UC)]: 60/26, male/female: 52/34, age at diagnosis: 30 year…
Zitieren
Zitierempfehlung
M Csöndes, A Szabó, T Kárász, S Pekárdi, I Rácz (2013) Clinical experiences with Infliximab and Adalimumab in a single centre cohort of patients with inflammatory bowel disease. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0033-1347461
Mit CareLit weiterarbeiten